Etanercept/infliximab/lamivudineHepatitis B reactivation: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1419卷 / 1期

关键词：

Infliximab; Etanercept; Lamivudine; Adefovir; Entecavir;

D O I：

10.2165/00128415-201214190-00076

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：20 / 20

相关论文

共 50 条

[11] Etanercept/infliximab/methotrexateUnmasking of linear psoriasis: 4 case reports
Reactions Weekly, 2018, 1718 (1) : 104 - 104
[12] Etanercept/infliximabUveitis (first report for infliximab): 5 case reports
Reactions Weekly, 2008, 1204 (1) : 16 - 16
[13] Adalimumab/etanercept/infliximab/rituximabVarious toxicities: 33 case reports
Reactions Weekly, 2015, 1550 (1) : 12 - 12
[14] Adalimumab/etanercept/infliximabPsoriasis or psoriasis reactivation: 15 case reports
Reactions Weekly, 2008, 1210 (1) : 6 - 6
[15] ImmunosuppressantsHepatitis B virus reactivation: 3 case reports
Reactions Weekly, 2019, 1764 (1) : 172 - 172
[16] Methotrexate/ustekinumabHepatitis B reactivation: 3 case reports
Reactions Weekly, 2018, 1726 (1) : 235 - 235
[17] PrednisoloneHepatitis B virus reactivation: 3 case reports
Reactions Weekly, 2022, 1887 (1) : 584 - 584
[18] Antineoplastics/thalidomideHepatitis B reactivation: 3 case reports
Reactions Weekly, 2015, 1547 (1) : 36 - 36
[19] AntineoplasticsHepatitis B virus reactivation: 3 case reports
Reactions Weekly, 2019, 1736 (1) : 35 - 35
[20] Imatinib/nilotinibHepatitis B reactivation: 3 case reports
Reactions Weekly, 2013, 1451 (1) : 25 - 25

← 1 2 3 4 5 →